SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-22-003426
Filing Date
2022-02-04
Accepted
2022-02-04 17:21:07
Documents
1
Period of Report
2022-02-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5785
  Complete submission text file 0001127602-22-003426.txt   7299
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Issuer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVROBIO, INC. ONE KENDALL SQUARE, BLDG 300 - SUITE 201 CAMBRIDGE MA 02139
Business Address
Ridha Essra (Reporting) CIK: 0001888732 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38537 | Film No.: 22594622